These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system. Fezza F, De Simone C, Amadio D, Maccarrone M. Subcell Biochem; 2008; 49():101-32. PubMed ID: 18751909 [Abstract] [Full Text] [Related]
3. Vanilloid receptor 1 (TRPV1/VR1) co-localizes with fatty acid amide hydrolase (FAAH) in retinal amacrine cells. Zimov S, Yazulla S. Vis Neurosci; 2007; 24(4):581-91. PubMed ID: 17686199 [Abstract] [Full Text] [Related]
4. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs. Gaetani S, Dipasquale P, Romano A, Righetti L, Cassano T, Piomelli D, Cuomo V. Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961 [Abstract] [Full Text] [Related]
5. Modulation of the endocannabinoid-degrading enzyme fatty acid amide hydrolase by follicle-stimulating hormone. Grimaldi P, Rossi G, Catanzaro G, Maccarrone M. Vitam Horm; 2009; 81():231-61. PubMed ID: 19647115 [Abstract] [Full Text] [Related]
6. Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages. Varani K, Bachoud-Lévi AC, Mariotti C, Tarditi A, Abbracchio MP, Gasperi V, Borea PA, Dolbeau G, Gellera C, Solari A, Rosser A, Naji J, Handley O, Maccarrone M, Peschanski M, DiDonato S, Cattaneo E. Neurobiol Dis; 2007 Jul; 27(1):36-43. PubMed ID: 17512749 [Abstract] [Full Text] [Related]
7. Endocannabinoids, hormone-cytokine networks and human fertility. Maccarrone M, Falciglia K, Di Rienzo M, Finazzi-Agrò A. Prostaglandins Leukot Essent Fatty Acids; 2002 Jul; 66(2-3):309-17. PubMed ID: 12052045 [Abstract] [Full Text] [Related]
8. Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage. Trabucco E, Acone G, Marenna A, Pierantoni R, Cacciola G, Chioccarelli T, Mackie K, Fasano S, Colacurci N, Meccariello R, Cobellis G, Cobellis L. Placenta; 2009 Jun; 30(6):516-22. PubMed ID: 19419760 [Abstract] [Full Text] [Related]
12. Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain. Cristino L, Starowicz K, De Petrocellis L, Morishita J, Ueda N, Guglielmotti V, Di Marzo V. Neuroscience; 2008 Feb 19; 151(4):955-68. PubMed ID: 18248904 [Abstract] [Full Text] [Related]
13. Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease. Bisogno T, Martire A, Petrosino S, Popoli P, Di Marzo V. Neurochem Int; 2008 Jan 19; 52(1-2):307-13. PubMed ID: 17664017 [Abstract] [Full Text] [Related]
14. The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women. Monteleone P, Tortorella A, Martiadis V, Di Filippo C, Canestrelli B, Maj M. Psychoneuroendocrinology; 2008 May 19; 33(4):546-50. PubMed ID: 18295974 [Abstract] [Full Text] [Related]
15. The role of fatty acid hydrolase gene variants in inflammatory bowel disease. Storr M, Emmerdinger D, Diegelmann J, Yüce B, Pfennig S, Ochsenkühn T, Göke B, Lohse P, Brand S. Aliment Pharmacol Ther; 2009 Mar 01; 29(5):542-51. PubMed ID: 19053981 [Abstract] [Full Text] [Related]
16. The fatty acid amide hydrolase in lymphocytes from sedentary and active subjects. Gasperi V, Ceci R, Tantimonaco M, Talamonti E, Battista N, Parisi A, Florio R, Sabatini S, Rossi A, Maccarrone M. Med Sci Sports Exerc; 2014 Jan 01; 46(1):24-32. PubMed ID: 23793235 [Abstract] [Full Text] [Related]
17. Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids. Steffens M, Schulze-Bonhage A, Surges R, Feuerstein TJ. Neurosci Lett; 2005 Sep 02; 385(1):13-7. PubMed ID: 15923084 [Abstract] [Full Text] [Related]
18. The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases. Maccarrone M, Battista N, Centonze D. Prog Neurobiol; 2007 Apr 02; 81(5-6):349-79. PubMed ID: 17276576 [Abstract] [Full Text] [Related]
19. Hydrolysis of prostaglandin glycerol esters by the endocannabinoid-hydrolyzing enzymes, monoacylglycerol lipase and fatty acid amide hydrolase. Vila A, Rosengarth A, Piomelli D, Cravatt B, Marnett LJ. Biochemistry; 2007 Aug 21; 46(33):9578-85. PubMed ID: 17649977 [Abstract] [Full Text] [Related]
20. Degradation of endocannabinoids in chronic migraine and medication overuse headache. Cupini LM, Costa C, Sarchielli P, Bari M, Battista N, Eusebi P, Calabresi P, Maccarrone M. Neurobiol Dis; 2008 May 21; 30(2):186-9. PubMed ID: 18358734 [Abstract] [Full Text] [Related] Page: [Next] [New Search]